HB 1397 Maryland House of Delegates · 2022 Regular Session

Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)

Bill status signed all 5 stages cleared

Introduction

Feb 2022

Committee Review

Apr 2022

House of Delegates Passage

Apr 2022

Senate Passage

Apr 2022

Signed into Law

May 2022

Introduced Feb 17, 2022 Signed May 16, 2022

Floor votes · Senate Mar 25, 2022 · House of Delegates Mar 14, 2022

How they voted

37–0

Passed · 1 other

Total votes 38

Mar 25, 2022

D Democratic24

23 Yea 1

95% Yea

R Republican14

14 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

May 16, 2022

Signed into law

Approved by the Governor - Chapter 405

executive

Apr 7, 2022

Lower · Passed

Returned Passed

lower

Apr 6, 2022

Upper · Passed

Third Reading Passed

upper

Apr 5, 2022

Upper · Passed

Favorable Adopted

upper

Apr 4, 2022

Upper · Passed

Favorable Report by Finance

upper

Mar 25, 2022

Senate · Passed

Senate Vote: pass (37-0-1)

senate

Mar 21, 2022

Committee

Referred Finance

upper

Mar 21, 2022

Lower · Passed

Third Reading Passed

lower

Mar 18, 2022

Lower · Passed

Favorable with Amendments {

lower

Mar 18, 2022

Lower · Passed

Favorable with Amendments Report by Health and Government Operations

lower

Mar 14, 2022

House Of Delegates · Passed

House of Delegates Vote: pass (111-0-10)

house of delegates

Mar 3, 2022

Committee

Rereferred to Health and Government Operations

lower

Feb 17, 2022

Committee

First Reading House Rules and Executive Nominations

lower

30 primary · 0 co-sponsors

Sponsors

Role

Legislator

Party

State

District

Cheryl Summers Landis

Geraldine Valentino-Smith

Heather Bagnall Tudball